Tag: Vaccines
New Threshold Could Inform Rabies Postexposure Prophylaxis Decisions
Authors say a risk threshold of 0.0004 would be appropriate for postexposure prophylaxis administration
Chikungunya Vaccine Candidate Induces Strong Immune Response
VLA1553 induced seroprotective chikungunya virus neutralizing antibody levels in 98.9 percent of those receiving vaccine
Bladder Cancer Treatment May Lower Risk for Alzheimer and Related Dementias
Greater effect seen for patients aged 70 years and older at time of bacillus Calmette-Guerin vaccination
Decreases in Mpox Vaccination Shortfall Needed in Minorities
To achieve equitable progression in vaccination, decreases in shortfalls needed for Black, AI/AN persons
Third Dose of COVID-19 Vaccine Seems Safe for Young Children
No new safety concerns reported among children aged 6 months to 5 years receiving third dose of mRNA COVID-19 vaccine
FDA Panel Backs RSV Vaccine for Infants, Some Toddlers
Monoclonal antibody shot would protect against RSV in infants born during or entering their first RSV season
FDA Approves Pfizer RSV Vaccine for Older Adults
CDC expected to meet later in the month to adopt vaccine recommendations for older Americans
More Parents Citing Safety as Reason for HPV Vaccine Hesitancy
2010 to 2018 saw 15.6 percent annual increase in proportion of parents citing 'safety or side effects' as reason for hesitancy
2011 to 2020 Saw Steady Improvement in Childhood Vaccine Adherence
Significant declines seen in patterns of no vaccination, selective vaccination, shot limiting
JYNNEOS Vaccine Seems Effective for Preventing Mpox
Two-dose series offers better protection, with vaccine effectiveness of 66.0 percent compared with 35.8 percent for one-dose
